Merck MRK
NYSE MRK
$145.93 +0.74 (+0.51%)
As of: Oct 16, 2026 · 3:59 PM EDT

Merck (MRK) Other Operating Expenses (2010 - 2011)

Updated

Merck's Other Operating Expenses was -$1 billion in Q2 2011.

Analysis

Merck (MRK) Other Operating Expenses (2010 - 2011) Analysis & Trends

For FY2010, Other Operating Expenses at Merck came in at -$950 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 -1.00 Bn
Mar 31, 2011 500.00 Mn
Sep 30, 2010 -950.00 Mn
API Access

Merck Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=MRK&period=max&api_key=YOUR_API_KEY